Literature DB >> 29290153

The Role of Heparan Sulfate in Inflammation, and the Development of Biomimetics as Anti-Inflammatory Strategies.

Brooke L Farrugia1, Megan S Lord1, James Melrose1,2,3, John M Whitelock1.   

Abstract

Key events that occur during inflammation include the recruitment, adhesion, and transmigration of leukocytes from the circulation to the site of inflammation. These events are modulated by chemokines, integrins, and selectins and the interaction of these molecules with glycosaminoglycans, predominantly heparan sulfate (HS). The development of HS/heparin mimetics that interfere or inhibit the interactions that occur between glycosaminoglycans and modulators of inflammation holds great potential for use as anti-inflammatory therapeutics. This review will detail the role of HS in the events that occur during inflammation, their interaction and modulation of inflammatory mediators, and the current advances in the development of HS/heparin mimetics as anti-inflammatory biotherapeutics.

Entities:  

Keywords:  extracellular matrix; glycosaminoglycans; heparan sulfate; heparin; inflammation; innate immunity

Mesh:

Substances:

Year:  2018        PMID: 29290153      PMCID: PMC5958377          DOI: 10.1369/0022155417740881

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  128 in total

1.  The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity.

Authors:  A E Proudfoot; S Fritchley; F Borlat; J P Shaw; F Vilbois; C Zwahlen; A Trkola; D Marchant; P R Clapham; T N Wells
Journal:  J Biol Chem       Date:  2000-12-14       Impact factor: 5.157

2.  Endothelial heparan sulfate controls chemokine presentation in recruitment of lymphocytes and dendritic cells to lymph nodes.

Authors:  Xingfeng Bao; E Ashley Moseman; Hideo Saito; Bronislawa Petryniak; Bronislawa Petryanik; Aude Thiriot; Shingo Hatakeyama; Yuki Ito; Hiroto Kawashima; Yu Yamaguchi; John B Lowe; Ulrich H von Andrian; Minoru Fukuda
Journal:  Immunity       Date:  2010-11-24       Impact factor: 31.745

3.  The Interaction of Heparin Tetrasaccharides with Chemokine CCL5 Is Modulated by Sulfation Pattern and pH.

Authors:  Arunima Singh; Warren C Kett; India C Severin; Isaac Agyekum; Jiana Duan; I Jonathan Amster; Amanda E I Proudfoot; Deirdre R Coombe; Robert J Woods
Journal:  J Biol Chem       Date:  2015-04-23       Impact factor: 5.157

4.  Comparison of anticoagulant and anti-inflammatory responses using enoxaparin versus unfractionated heparin for transesophageal echocardiography-guided cardioversion of atrial fibrillation.

Authors:  Debra Hoppensteadt; Jawed Fareed; Allan L Klein; Susan E Jasper; Carolyn Apperson-Hansen; Elizabeth A Lieber; William E Katz; Joseph F Malouf; Marcus F Stoddard; Linda A Pape
Journal:  Am J Cardiol       Date:  2008-07-09       Impact factor: 2.778

5.  Low molecular weight heparin inhibits tumor necrosis factor alpha-induced leukocyte rolling.

Authors:  M X Wan; X W Zhang; L Törkvist; H Thorlacius
Journal:  Inflamm Res       Date:  2001-12       Impact factor: 4.575

6.  Glycosaminoglycans mediate cell surface oligomerization of chemokines.

Authors:  A J Hoogewerf; G S Kuschert; A E Proudfoot; F Borlat; I Clark-Lewis; C A Power; T N Wells
Journal:  Biochemistry       Date:  1997-11-04       Impact factor: 3.162

7.  Role of endothelial heparanase in delayed-type hypersensitivity.

Authors:  Evgeny Edovitsky; Immanuel Lerner; Eyal Zcharia; Tamar Peretz; Israel Vlodavsky; Michael Elkin
Journal:  Blood       Date:  2005-12-29       Impact factor: 22.113

8.  Inhibition of selectin-mediated cell adhesion and prevention of acute inflammation by nonanticoagulant sulfated saccharides. Studies with carboxyl-reduced and sulfated heparin and with trestatin a sulfate.

Authors:  X Xie; A S Rivier; A Zakrzewicz; M Bernimoulin; X L Zeng; H P Wessel; M Schapira; O Spertini
Journal:  J Biol Chem       Date:  2000-11-03       Impact factor: 5.157

9.  The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.

Authors:  J M Whitelock; A D Murdoch; R V Iozzo; P A Underwood
Journal:  J Biol Chem       Date:  1996-04-26       Impact factor: 5.157

10.  Endothelial heparan sulfate proteoglycans that bind to L-selectin have glucosamine residues with unsubstituted amino groups.

Authors:  K Norgard-Sumnicht; A Varki
Journal:  J Biol Chem       Date:  1995-05-19       Impact factor: 5.157

View more
  24 in total

1.  Secretory expression of the rat aryl sulfotransferases IV with improved catalytic efficiency by molecular engineering.

Authors:  Zhengxiong Zhou; Qing Li; Ruirui Xu; Bingbing Wang; Guocheng Du; Zhen Kang
Journal:  3 Biotech       Date:  2019-06-03       Impact factor: 2.406

Review 2.  Effect of Polarization and Chronic Inflammation on Macrophage Expression of Heparan Sulfate Proteoglycans and Biosynthesis Enzymes.

Authors:  Maarten Swart; Linda Troeberg
Journal:  J Histochem Cytochem       Date:  2018-09-11       Impact factor: 2.479

3.  Inhibition of heparanase protects against chronic kidney dysfunction following ischemia/reperfusion injury.

Authors:  Valentina Masola; Gloria Bellin; Gisella Vischini; Luigi Dall'Olmo; Simona Granata; Giovanni Gambaro; Antonio Lupo; Maurizio Onisto; Gianluigi Zaza
Journal:  Oncotarget       Date:  2018-11-16

Review 4.  Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity.

Authors:  Cinzia Lanzi; Giuliana Cassinelli
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

5.  Diabetic endothelial colony forming cells have the potential for restoration with glycomimetics.

Authors:  Alexander W W Langford-Smith; Ahmad Hasan; Ria Weston; Nicola Edwards; Alan M Jones; Andrew J M Boulton; Frank L Bowling; S Tawqeer Rashid; Fiona L Wilkinson; M Yvonne Alexander
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

6.  Heparin - An old drug with multiple potential targets in Covid-19 therapy.

Authors:  Ulf Lindahl; Jin-Ping Li
Journal:  J Thromb Haemost       Date:  2020-08-27       Impact factor: 16.036

7.  A Synthetic Cell-Penetrating Heparin-Binding Peptide Derived from BMP4 with Anti-Inflammatory and Chondrogenic Functions for the Treatment of Arthritis.

Authors:  Da Hyeon Choi; Dongwoo Lee; Beom Soo Jo; Kwang-Sook Park; Kyeong Eun Lee; Ju Kwang Choi; Yoon Jeong Park; Jue-Yeon Lee; Yoon Shin Park
Journal:  Int J Mol Sci       Date:  2020-06-15       Impact factor: 5.923

Review 8.  Glycosaminoglycans as Multifunctional Anti-Elastase and Anti-Inflammatory Drugs in Cystic Fibrosis Lung Disease.

Authors:  Judith A Voynow; Shuo Zheng; Apparao B Kummarapurugu
Journal:  Front Pharmacol       Date:  2020-07-08       Impact factor: 5.810

Review 9.  Mucopolysaccharidosis Type I: A Review of the Natural History and Molecular Pathology.

Authors:  Christiane S Hampe; Julie B Eisengart; Troy C Lund; Paul J Orchard; Monika Swietlicka; Jacob Wesley; R Scott McIvor
Journal:  Cells       Date:  2020-08-05       Impact factor: 6.600

Review 10.  Development and use of biomaterials as wound healing therapies.

Authors:  Rachael Zoe Murray; Zoe Elizabeth West; Allison June Cowin; Brooke Louise Farrugia
Journal:  Burns Trauma       Date:  2019-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.